Pharmacy Investors, LLC - 28 Mar 2025 Form 4 Insider Report for Guardian Pharmacy Services, Inc. (GRDN)

Role
Member of 10% owner group
Signature
/s/ Douglas Towns, Attorney-in-Fact
Issuer symbol
GRDN
Transactions as of
28 Mar 2025
Net transactions value
-$19,440,611
Form type
4
Filing time
30 Sep 2025, 16:10:05 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pharmacy Investors, LLC Member of 10% owner group 401 PENNSYLVANIA PARKWAY, SUITE 100, INDIANAPOLIS /s/ Douglas Towns, Attorney-in-Fact 30 Sep 2025 0002038519

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GRDN Class A Common Stock Sale $16,396,491 -813,318 -58% $20.16 600,622 27 May 2025 Direct F1
transaction GRDN Class A Common Stock Sale $3,044,120 -150,998 -25% $20.16 449,624 28 May 2025 Direct F1
transaction GRDN Class A Common Stock Options Exercise +1,413,940 +314% 1,863,564 27 Sep 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRDN Class B Common Stock Options Exercise -1,413,940 -33% 2,827,878 27 Sep 2025 Class A Common Stock 1,413,940 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Guardian Pharmacy Services, Inc.'s (the "Issuer") Class A common stock sold pursuant to the Underwriting Agreement, dated May 22, 2025, by and among the Issuer, the selling stockholders party thereto and Raymond James & Associates, Inc., as representative of the several underwriters named therein.
F2 Pursuant to the Issuer's Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026.